Gastroesophageal Reflux Disease As an Indication of Revisional Bariatric Surgery—Indication and Results

Gastroesophageal Reflux Disease As an Indication of Revisional Bariatric Surgery—Indication and Results—A Systematic Review and Metanalysis Publisher Pubmed

Chiappetta S¹ ; Lainas P^{2, 3} ; Kassir R^{4, 5} ; Valizadeh R⁶ ; Bosco A¹ ; Kermansaravi M⁷

Show Affiliations

1. Bariatric and Metabolic Surgery Unit, Department of General Surgery, Ospedale Evangelico Betania, Via Argine 604, Naples, 80147, Italy
2. Department of Digestive Surgery, Metropolitan Hospital, HEAL Academy, Athens, Greece
3. Department of Minimally Invasive Digestive Surgery, Antoine-Beclere Hospital, Paris-Saclay University, Clamart, France
4. Digestive Surgery Unit, University Hospital of La Reunion -Felix Guyon Hospital, Saint-Denis, La Reunion, France
5. Diabete Atherothrombose Therapies Reunion Ocean Indien (DeTROI), UMR 1188, INSERM, Universite de La Reunion, Saint Denis, 97400, France
6. Department of Epidemiology, School of Public Health, University of Medical Sciences, Tehran, Iran
7. Minimally Invasive Surgery Research Center, Division of Minimally Invasive and Bariatric Surgery, Department of SurgeryRasool-E Akram Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Source: Obesity Surgery Published:2022

Abstract

This systematic review evaluates the indications and results of revisional bariatric surgery (RBS) in gastroesophageal reflux disease (GERD). A systematic literature search and meta-analysis was performed for articles published by April 1, 2021. After examining 722 papers involving 17,437 patients, 48 studies were included (n = 915 patients). RBS for GERD was mostly reported after sleeve gastrectomy (n = 796, 87%) and one anastomosis gastric bypass (n = 62, 6.8%) and was performed due to intractable GERD (71.6%), GERD and weight issues (16%), and biliary reflux (6.2%). Mean follow-up of the studies was 31.5 (3–84) months. Pooled estimation of a meta-analysis of studies reported 7% of GERD following primary surgery needing RBS, in which 99% of the patients experienced remission. Graphical abstract: [Figure not available: see fulltext.] © 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Related Docs

View other Related Docs

1. Postoperative Outcomes and Advantages of Hand-Sewn Laparoscopic One-Anastomosis Gastric Bypass: Experience on 805 Patients, Obesity Surgery (2021)

2. Food Insecurity and Anaemia Risk: A Systematic Review and Meta-Analysis, Public Health Nutrition (2018)

3. Selenium Deficiency After Bariatric Surgery, Incidence and Symptoms: A Systematic Review and Meta-Analysis, Obesity Surgery (2022)

4. Dietary Intake of Linoleic Acid, Its Concentrations, and the Risk of Type 2 Diabetes: A Systematireview and Dose-Response Meta-Analysis of Prospective Cohort Studies, Diabetes Care (2021)

5. Tim Family Gene Polymorphism and Susceptibility to Rheumatoid Arthritis: Systematic Review and Meta-Analysis, PLoS ONE (2019)

6. Dietary Antioxidants, Circulating Antioxidant Concentrations, Total Antioxidant Capacity, and Risk of All-Causemortality: A Systematic Review and Dose-Responsemeta-Analysis of Prospective Observational Studies, Advances in Nutrition (2018)

7. Letter to the Editor About the Article “A Systematic Review and Meta-Analysis of the Effect of Bisphosphonate Drug Holidays on Bone Mineral Density and Osteoporotic Fracture Risk”, Osteoporosis International (2019)

8. Factors Associated With Hiv Testing Among People Who Inject Drugs: A Meta-Analysis, Journal of Addictive Diseases (2020)

Experts (# of related papers)

View all Related Experts

Sakineh Shab-Bidar (10)

Bagher Larijani (6)

Style	Citing Format
MLA	Chiappetta S, et al.. "Gastroesophageal Reflux Disease As an Indication of Revisional Bariatric Surgery—Indication and Results—A Systematic Review and Metanalysis." Obesity Surgery, vol. 32, no. 9, 2022, pp. 3156-3171.
APA	Chiappetta S, Lainas P, Kassir R, Valizadeh R, Bosco A, Kermansaravi M (2022). Gastroesophageal Reflux Disease As an Indication of Revisional Bariatric Surgery—Indication and Results—A Systematic Review and Metanalysis. Obesity Surgery, 32(9), 3156-3171.
Chicago	Chiappetta S, Lainas P, Kassir R, Valizadeh R, Bosco A, Kermansaravi M. "Gastroesophageal Reflux Disease As an Indication of Revisional Bariatric Surgery—Indication and Results—A Systematic Review and Metanalysis." Obesity Surgery 32, no. 9 (2022): 3156-3171.
Harvard	Chiappetta S et al. (2022) 'Gastroesophageal Reflux Disease As an Indication of Revisional Bariatric Surgery—Indication and Results—A Systematic Review and Metanalysis', Obesity Surgery, 32(9), pp. 3156-3171.
Vancouver	Chiappetta S, Lainas P, Kassir R, Valizadeh R, Bosco A, Kermansaravi M. Gastroesophageal Reflux Disease As an Indication of Revisional Bariatric Surgery—Indication and Results—A Systematic Review and Metanalysis. Obesity Surgery. 2022;32(9):3156-3171.
BibTex	@article{ author = {Chiappetta S and Lainas P and Kassir R and Valizadeh R and Bosco A and Kermansaravi M}, title = {Gastroesophageal Reflux Disease As an Indication of Revisional Bariatric Surgery—Indication and Results—A Systematic Review and Metanalysis}, journal = {Obesity Surgery}, volume = {32}, number = {9}, pages = {3156-3171}, year = {2022} }
RIS	TY - JOUR AU - Chiappetta S AU - Lainas P AU - Kassir R AU - Valizadeh R AU - Bosco A AU - Kermansaravi M TI - Gastroesophageal Reflux Disease As an Indication of Revisional Bariatric Surgery—Indication and Results—A Systematic Review and Metanalysis JO - Obesity Surgery VL - 32 IS - 9 SP - 3156 EP - 3171 PY - 2022 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract